Advisornet Financial’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,000
Closed -$69.4K 2060
2024
Q3
$69.4K Buy
10,000
+3,000
+43% +$23.5K 0.01% 802
2024
Q2
$54.6K Sell
7,000
-3,000
-30% -$22.2K 0.01% 796
2024
Q1
$71K Sell
10,000
-6
-0.1% -$40 0.01% 717
2023
Q4
$67K Buy
10,006
+4
+0% +$23 0.01% 738
2023
Q3
$56.3K Buy
10,002
+2
+0% +$13 0.01% 755
2023
Q2
$55.2K Buy
10,000
+4,948
+98% +$26.6K ﹤0.01% 785
2023
Q1
$31.6K Buy
5,052
+2
+0% +$11 ﹤0.01% 930
2022
Q4
$23.5K Hold
5,050
﹤0.01% 1005
2022
Q3
$24K Buy
5,050
+1,000
+25% +$6.3K ﹤0.01% 1053
2022
Q2
$24K Buy
4,050
+2,175
+116% +$24.2K ﹤0.01% 1070
2022
Q1
$36K Buy
1,875
+1,375
+275% +$31.5K ﹤0.01% 1072
2021
Q4
$16K Sell
500
-1,925
-79% -$77.4K ﹤0.01% 1348
2021
Q3
$99K Buy
2,425
+500
+26% +$18.1K 0.01% 792
2021
Q2
$69K Buy
+1,925
New +$71K ﹤0.01% 889

Other funds holding GDRX

Advisornet Financial's GDRX Position: Q4 2024 in Review

Advisornet Financial sold out of GoodRx Holdings (GDRX) in Q4 2024, closing a stake of 10,000 shares — an estimated $69.4K sold.

Advisornet Financial first reported a position in GDRX in Q2 2021 and held it in 14 quarters. The position peaked at $99K in Q3 2021. 170 funds tracked by Wall St. Rank hold GDRX as of Q4 2024.

  • Advisornet Financial reported no remaining GoodRx Holdings position as of Q4 2024 after selling out during the quarter.
  • Advisornet Financial sold 10,000 GoodRx Holdings shares in Q4 2024, an estimated $69.4K.
  • Advisornet Financial first reported a position in GoodRx Holdings in Q2 2021 and held it in 14 quarters.
  • Advisornet Financial's GoodRx Holdings position peaked at $99K in Q3 2021.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2024.

Based on Advisornet Financial's 13F filing for Q4 2024, filed 13 Jan 2025.